<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – Specific Aims (Phase I)</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="description" content="Specific Aims (Phase I): PromptGenix – BioAI Automation Platform."/>
  <style>
    * { box-sizing: border-box; }
    body{
      margin:0;
      font-family:-apple-system,BlinkMacSystemFont,"Segoe UI",sans-serif;
      background:#020617;
      color:#e5e7eb;
      line-height:1.5;
    }
    a{ color:inherit; text-decoration:none; }
    .page{ min-height:100vh; display:flex; flex-direction:column; }

    /* Header/nav (matches your SBIR portal pages) */
    header{
      position:sticky; top:0; z-index:30;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }
    .nav{
      max-width:1120px; margin:0 auto; padding:14px 20px;
      display:flex; align-items:center; justify-content:space-between; gap:18px;
    }
    .nav-left{ display:flex; align-items:center; gap:12px; }
    .logo-dot{
      width:28px; height:28px; border-radius:999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow:0 0 18px rgba(56,189,248,.7);
    }
    .brand{ font-size:1.1rem; font-weight:650; letter-spacing:.04em; }
    .subbrand{ font-size:.72rem; color:#9ca3af; margin-top:2px; }

    .nav-links{ display:flex; gap:10px; flex-wrap:wrap; justify-content:flex-end; }
    .nav-links a{
      font-size:.88rem; color:#9ca3af;
      padding:6px 10px; border-radius:999px;
      border:1px solid rgba(148,163,184,0.18);
      background: rgba(2,6,23,0.25);
    }
    .nav-links a:hover{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.35);
    }
    .nav-links a.active{
      color:#e5e7eb;
      background: rgba(148,163,184,0.18);
      border-color: rgba(148,163,184,0.55);
    }

    main{ flex:1; }

    .section{
      max-width: 980px;
      margin: 0 auto;
      padding: 22px 20px 28px;
    }

    .doc-title{
      font-size: 1.28rem;
      font-weight: 820;
      color:#f9fafb;
      margin: 12px 0 4px;
    }
    .meta{
      font-size:.78rem;
      color:#9ca3af;
      margin-bottom: 12px;
    }

    .kicker{
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .18em;
      color: #a5b4fc;
      margin: 14px 0 6px;
    }

    p{
      margin: 0 0 10px;
      font-size: .92rem;
      color:#d1d5db;
    }

    .box{
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px solid rgba(148,163,184,0.35);
      background: rgba(15,23,42,0.78);
      margin: 10px 0 12px;
      box-shadow: 0 18px 45px rgba(15,23,42,0.45);
    }
    .box strong{ color:#22c55e; }

    ul{
      margin: 6px 0 0;
      padding-left: 1.08rem;
      color:#d1d5db;
      font-size: .92rem;
    }
    li{ margin-bottom: 6px; }
    li strong{ color:#e5e7eb; }

    .fine{
      font-size:.78rem;
      color:#9ca3af;
      margin-top: 10px;
    }

    footer{
      border-top:1px solid rgba(31,41,55,0.9);
      padding:16px;
      font-size:.78rem;
      color:#6b7280;
      text-align:center;
    }

    /* =========================
       PRINT CONFIG (SBIR PDF)
       - Website view: unchanged
       - Print/PDF: stable, compact, readable
       ========================= */
    @media print {
      @page { size: Letter; margin: 0.5in; }
      header, footer { display: none !important; }

      body{ background:#fff; color:#111; }
      p, li, .meta, .fine{ color:#111 !important; }
      .kicker{ color:#111 !important; letter-spacing:.14em; }
      .box{ border:1px solid #999; background:#fff; box-shadow:none; }
      .section{ max-width: 100%; padding: 0; }

      /* gentle compression to keep 1 page without tiny scaling */
      body{ font-size: 96%; line-height: 1.33; }
      .doc-title{ margin-top: 0; }
      li{ margin-bottom: 4px; }

      /* reduce chance of awkward splits */
      .box, ul { break-inside: avoid; page-break-inside: avoid; }
      .kicker{ page-break-after: avoid; }
      p, li{ orphans: 3; widows: 3; }
    }
  </style>
</head>

<body>
<div class="page">
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div class="subbrand">SBIR Portal</div>
        </div>
      </div>
      <nav class="nav-links">
        <a href="index.html">Portal</a>
        <a href="sbir.html">SBIR</a>
        <a href="aims.html" class="active">Aims</a>
        <a href="approach.html">Approach</a>
        <a href="commercialization.html">Commercialization</a>
        <a href="facilities.html">Facilities</a>
        <a href="team.html">Team</a>
        <a href="use-cases.html">Use Cases</a>
      </nav>
    </div>
  </header>

  <main>
    <section class="section">

      <div class="doc-title">Specific Aims (Phase I): PromptGenix – BioAI Automation Platform</div>
      <div class="meta">
        PromptGenix LLC (Women &amp; Minority-Owned) &middot; Contact: dohoon.kim1@icloud.com &middot; Website: promptgenix.org/sbir.html
      </div>

      <div class="kicker">Significance</div>
      <p>
        Infectious disease and immunology programs generate large volumes of RNA-Seq, scRNA-Seq, and high-dimensional flow cytometry data,
        yet analysis remains fragmented across tools, custom scripts, and limited expert time. This slows turnaround, reduces reproducibility,
        and delays actionable biological interpretation and experiment planning.
      </p>

      <div class="kicker">Innovation</div>
      <p>
        PromptGenix integrates end-to-end automated omics pipelines with an internal, literature-aware LLM layer and a
        <strong>traceable Hypothesis Generator</strong> that ranks mechanistic hypotheses and proposes concrete validation experiments.
        Unlike generic summarizers, PromptGenix links every claim to observed pipeline outputs and/or PubMed-style citations with uncertainty labels.
      </p>

      <div class="kicker">Overall objective &amp; central hypothesis</div>
      <div class="box">
        <p style="margin:0 0 8px;">
          <strong>Objective:</strong> Deliver a validated, reproducible Phase I prototype that automates RNA-Seq and flow cytometry workflows and generates
          reviewer-ready reports with ranked hypotheses and suggested validation experiments.
        </p>
        <p style="margin:0;">
          <strong>Central hypothesis:</strong> Standardized automated pipelines plus traceable, literature-aware LLM reasoning will reduce analysis turnaround time
          and increase interpretability, enabling faster, higher-quality study design decisions in infectious disease and vaccine research.
        </p>
      </div>

      <div class="kicker">Specific aims</div>
      <ul>
        <li><strong>Aim 1:</strong> Harden end-to-end automated RNA-Seq and flow cytometry pipelines using public datasets (GEO/SRA/FlowRepository), with deterministic configs and versioned outputs.</li>
        <li><strong>Aim 2:</strong> Implement a traceable Hypothesis Generator that ranks hypotheses and proposes validation experiments with evidence-linked, PubMed-aware citations and confidence flags.</li>
        <li><strong>Aim 3:</strong> Produce exportable HTML/PDF reports (figures, tables, narrative, hypotheses, experiment plan) and evaluate usability/KPIs with 2–3 pilot-style public-data studies.</li>
      </ul>

      <div class="kicker">Expected outcomes &amp; deliverables</div>
      <ul>
        <li>Validated prototype producing reproducible outputs across reruns (versioned configs + reports).</li>
        <li>Reviewer-ready reports generated within &lt;24 hours from raw inputs (dataset-dependent).</li>
        <li>Measured improvements in turnaround time and user-rated usefulness of AI-generated hypotheses.</li>
      </ul>

      <div class="kicker">Impact</div>
      <p style="margin-bottom:0;">
        Phase I establishes technical feasibility and reviewer trust; Phase II will scale PromptGenix to multi-site cohorts and secure deployments,
        expand dataset coverage and UI/automation, and convert validated pilots into revenue-generating subscriptions and enterprise engagements.
      </p>

      <div class="fine">
        Phase I SBIR – NIH/NIAID focus &middot; Public-data validation &middot; Women &amp; Minority-Owned Small Business
      </div>

    </section>
  </main>

  <footer>
    PromptGenix &middot; SBIR Portal &middot; <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
